Axitinib-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic renal cell carcinoma

A 61-year-old woman with metastatic renal carcinoma was treated with axitinib as a second-line tyrosine kinase inhibitor. Thirteen days after the treatment, the patient developed reversible posterior leukoencephalopathy syndrome (RPLS). Her symptoms and imaging findings resolved after withdrawal of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Cancer Conf J
Main Authors: Nakamura, Kogenta, Saiki, Hiroshi, Muramatsu, Hiroyuki, Morinaga, Shingo, Kobayashi, Ikuo, Kajikawa, Keishi, Nishikawa, Genya, Kato, Yoshiharu, Watanabe, Masahito, Kanao, Kent, Sumitomo, Makoto
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498335/
https://ncbi.nlm.nih.gov/pubmed/31149502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0306-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados